Epidemiologie der Multiplen Sklerose

M. Paulig

doi:10.1055/s-0038-1628459

Nervenheilkunde, Table of Contents

Nervenheilkunde 2011; 30(12): 977-982
DOI: 10.1055/s-0038-1628459

Schwabinger Neuro-Seminar

Schattauer GmbH

Epidemiologie der Multiplen Sklerose

Befunde und InterpretationenEpidemiology of multiple sclerosisFindings and interpretations

M. Paulig

¹Abteilung für Neurologie und klinische Neurophysiologie, Schön Klinik, München Schwabing

› Author Affiliations

Abstract

Zusammenfassung

Seit Jahrzehnten ist bekannt, dass die Prävalenz der Multiplen Sklerose (MS) eine ungleiche Verteilung in verschiedenen Weltregionen und Populationen aufweist. Es gibt unterschiedliche Risikoszenarien für die geografische Herkunft, die ethnische Zugehörigkeit, das Geschlecht und das Lebensalter. Allerdings waren frühere Studien in ihrer Aussagekraft teilweise durch methodologische Probleme limitiert. Aktuelle Untersuchungen konnten ein detaillierteres Bild räumlicher und zeitlicher Aspekte der Prävalenz und Inzidenz der MS herausarbeiten. Interpretationen dieser Befunde sprechen sowohl für genetische als auch für umweltbedingte Einflüsse. Die Kenntnis hierüber könnte in Zukunft zu neuen Strategien in der Prävention und Behandlung der MS führen.

Summary

It has been known for decades that the prevalence of multiple sclerosis shows an uneven distribution among different regions of the world and different populations. There are varying risk scenarios arising from geography, ethnics, gender and age. However, the issue of epidemiological studies in the past was partially limited due to methodological problems. Recent studies have figured out a more detailed pattern of spatial and temporal aspects of the prevalence and incidence of multiple sclerosis. Interpretations of these data point to both genetically and environmentally driven influences. This knowledge may provide new strategies for the prevention and treatment of multiple sclerosis in the future.

Schlüsselwörter

Multiple Sklerose - Epidemiologie - Geografie - Lebensalter - Ethnien - Geschlecht

Keywords

Multiple sclerosis - epidemiology - geography - age - ethnics - gender

Full Text

References

Literatur
1 Ahlgren C, Odén A, Lycke J. High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler. 2011 Apr 1; Epub ahead of print
2 Alonso A, Cook SD, Maghzi AH, Divani AA. TA casecontrol study of risk factors for multiple sclerosis in Iran. Mult Scler. 2011 Feb 15; Epub ahead of print.
3 Alter M, Kahana E, Zilber N, Miller A. Multiple sclerosis frequency in Israel’s diverse populations. Neurology 2006; 66 (07) 1061-6.
4 Arias M, Dapena D, Arias-Rivas S, Costa E, López A, Prieto JM, Corredera E. Late onset multiple sclerosis. Neurologia 2011; 26 (05) 291-6.
5 Ascherio A, Munger KL. Epstein-barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 2010; 05 (03) 271-7.
6 Aulchenko YS. et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 2008; 40 (12) 1402-3.
7 Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007; 06 (10) 887-902.
8 Bayes HK, Weir CJ, O’Leary C. Timing of birth and risk of multiple sclerosis in the Scottish population. Eur Neurol 2010; 63 (01) 36-40.
9 Benedikz J, Magnússon H, Guthmundsson G. Multiple sclerosis in Iceland, with observations on the alleged epidemic in the Faroe Islands. Ann Neurol 1994; 36 Suppl 2 S175-9.
10 Binzer S. et al. Multiple sclerosis in a family on the Faroe Islands. Acta Neurol Scand 2010; 121 (01) 16-9.
11 Boström I, Callander M, Kurtzke JF, Landtblom AM. High prevalence of multiple sclerosis in the Swedish county of Värmland. Mult Scler 2009; 15 (11) 1253-62.
12 Buchanan RJ. et al. Comparisons of Latinos, African Americans, and Caucasians with multiple sclerosis. Ethn Dis 2010; 20 (04) 451-7.
13 Carswell R. Pathological Anatomy: Illustrations of the Elementary Forms of Disease. London: Orme, Brown, Green & Longman; 1838
14 Chao MJ. et al. MHC transmission: insights into gender bias in MS susceptibility. Neurology 2011; 76 (03) 242-6.
15 Charcot JM. Histologie de la sclérose en plaques. Gaz. Hôpital (Paris) 1868; 41: 554-66.
16 Cocco E. et al. Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler. 2011 Jun 7; Epub ahead of print..
17 Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006; 129 (03) 606-16.
18 Disanto G. et al. Heterogeneity in multiple sclerosis: scratching the surface of a complex disease. Autoimmune Dis 2010; 2011: 932351.
19 Ebers GC, Sadovnick AD. The geographic distribution of multiple sclerosis: a review. Neuroepidemiology 1993; 12 (01) 1-5.
20 Ferreira CCVasconcelos. et al. Differences in the progression of primary progressive multiple sclerosis in Brazilians of African descent versus white Brazilian patients. Mult Scler 2010; 16 (05) 597-603.
21 Frischer JM. et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132 (05) 1175-89.
22 Gilli F. et al. Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. PLoS One 2010; 05 (01) e8962.
23 Goodin DS. The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One 2009; 04 (02) e4565.
24 Hein T, Hopfenmüller W. Hochrechnung der Zahl an Multiple Sklerose erkrankten Patienten in Deutschland. Nervenarzt 2000; 71 (04) 288-94.
25 Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357 (03) 266-81.
26 Inshasi J, Thakre M. Prevalence of multiple sclerosis in Dubai, United Arab Emirates. Int J Neurosci. 2011, Apr 4; Epub ahead of print,.
27 Joensen P. Multiple sclerosis: variation of incidence of onset over time in the Faroe Islands. Mult Scler 2011; 17 (02) 241-4.
28 Johnson BA. et al. Multiple sclerosis susceptibility alleles in African Americans. Genes Immun 2010; 11 (04) 343-50.
29 Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010; 09 (05) 520-32.
30 Krökki O, Bloigu R, Reunanen M, Remes AM. Increasing incidence of multiple sclerosis in women in Northern Finland. Mult Scler 2011; 17 (02) 133-8.
31 Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol Scand 1975; 51 (02) 110-36.
32 Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993; 06 (04) 382-427.
33 Lucas RM. et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011; 76 (06) 540-8.
34 Mayr WT. et al. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000. Neurology 2003; 61 (10) 1373-7.
35 McDonald I. Multiple sclerosis in its European matrix. Mult Scler 2002; 08 (03) 181-91.
36 Ness JM. et al. Clinical features of children and adolescents with multiple sclerosis. Neurology 2007; 68 (16 Suppl 2) S37-45.
37 Orton SM. et al. Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study. J Neurol Neurosurg Psychiatry 2010; 81 (01) 31-6.
38 Poser CM. Viking voyages: the origin of multiple sclerosis? An essay in medical history. Acta Neurol Scand Suppl 1995; 161: 11-22.
39 Pugliatti M, Cossu P, Sotgiu S, Rosati G, Riise T. Clustering of multiple sclerosis, age of onset and gender in Sardinia. J Neurol Sci 2009; 286 (1–2) 6-13.
40 Pugliatti M. et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006; 13 (07) 700-22.
41 Ramagopalan SV, Hoang U, Seagroatt V, Handel A, Ebers GC, Giovannoni G, Goldacre MJ. Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study. J Neurol Neurosurg Psychiatry 2011; 82 (06) 682-7.
42 Risco J. et al. Latitudinal prevalence gradient of multiple sclerosis in Latin America. Mult Scler. 2011 May 6; Epub ahead of print.
43 Rivera VM. Multiple Sclerosis in Latin America. Reality and Challenge. Neuroepidemiology 2009; 32: 294-5.
44 Robertson NP. et al. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996; 119 (02) 449-55.
45 Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stüve O. The increasing incidence and prevalence of female multiple sclerosis-A critical analysis of potential environmental factors. Autoimmun Rev 2011; 10 (08) 495-502.
46 Simpson Jr S, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011 Apr 8; Epub ahead of print.
47 Weinstock-Guttman B. et al. Increased tissue damage and lesion volumes in African Americans with multiple sclerosis. Neurology 2010; 74 (07) 538-44.
48 Wu JS. et al. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study. Mult Scler 2010; 16 (05) 526-32.